Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-23-000837
Filing Date
2023-05-12
Accepted
2023-05-12 13:45:03
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 533305
2 CERTIFICATE bdpt_ex311.htm EX-31.1 11690
3 CERTIFICATE bdpt_ex312.htm EX-31.2 13543
4 CERTIFICATE bdpt_ex321.htm EX-32.1 4042
5 CERTIFICATE bdpt_ex322.htm EX-32.2 4751
11 bdpt_10qimg1.jpg GRAPHIC 3810
  Complete submission text file 0001640334-23-000837.txt   2792756

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20230331.xsd EX-101.SCH 26565
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20230331_lab.xml EX-101.LAB 164578
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20230331_cal.xml EX-101.CAL 31780
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20230331_pre.xml EX-101.PRE 138953
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20230331_def.xml EX-101.DEF 72465
44 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 394728
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 23914681
SIC: 2834 Pharmaceutical Preparations